BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2
607 results:

  • 1. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
    Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
    J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Six versus four or five cycles of first-line etoposide and platinum-based chemotherapy combined with thoracic radiotherapy in patients with limited-stage small-cell lung cancer: A propensity score-matched analysis of a prospective randomized trial.
    Yu TT; Hu X; Liufu WJ; Niu SQ; Lian HM; Ma HL; Wang J; Bao Y; Chen M; Peng F
    Cancer Med; 2024 Apr; 13(8):e7215. PubMed ID: 38659392
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Late-stage modification of complex drug: Base-controlled Pd-catalyzed regioselective synthesis and bioactivity of arylated osimertinibs.
    Feng R; Zhen YQ; Wu D; Sun L; Xu JB; Li X; Zhang L; Gao F
    Sci Adv; 2024 Mar; 10(10):eadl0026. PubMed ID: 38457511
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Phenome-wide association study of ovarian cancer identifies common comorbidities and reveals shared genetics with complex diseases and biomarkers.
    Mulugeta A; Lumsden AL; Madakkatel I; Stacey D; Lee SH; Mäenpää J; Oehler MK; Hyppönen E
    Cancer Med; 2024 Feb; 13(4):e7051. PubMed ID: 38457211
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis.
    Wang M; Hu S; Yang J; Yuan L; Han L; Liang F; Zhang F; Zhao H; Liu Y; Gao N
    Phytomedicine; 2024 May; 127():155391. PubMed ID: 38452690
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis.
    Yao Y; Li B; Song R; Yang L; Zou B; Wang L
    Radiat Oncol; 2024 Feb; 19(1):25. PubMed ID: 38413988
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Establishment of immortalized Egyptian Rousettus bat cell lines.
    Bai L; Tani T; Kobayashi T; Nouda R; Kanai Y; Sano Y; Takami K; Tomita H; Sugano E; Ozaki T; Kiyono T; Fukuda T
    FEBS Open Bio; 2024 Apr; 14(4):598-612. PubMed ID: 38373743
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomic characteristics and immune landscape of super multiple primary lung cancer.
    Yang Z; Zhou B; Guo W; Peng Y; Tian H; Xu J; Wang S; Chen X; Hu B; Liu C; Wang Z; Li C; Gao S; He J
    EBioMedicine; 2024 Mar; 101():105019. PubMed ID: 38364701
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients.
    Yin H; Jia W; Yu J; Zhu H
    BMC Cancer; 2024 Feb; 24(1):197. PubMed ID: 38347438
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer.
    Wang Y; Gao Z; Zhao W; Li H; Meng X; Li J
    Thorac Cancer; 2024 Mar; 15(8):642-653. PubMed ID: 38323356
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
    Longo V; Della Corte CM; Russo A; Spinnato F; Ambrosio F; Ronga R; Marchese A; Del Giudice T; Sergi C; Casaluce F; Gilli M; Montrone M; Gristina V; Sforza V; Reale ML; Di Liello R; Servetto A; Lipari H; Longhitano C; Vizzini L; Manzo A; Cristofano A; Paolelli L; Nardone A; De Summa S; Perrone A; Bisceglia C; Derosa C; Nardone V; Viscardi G; Galetta D; Vitiello F
    Front Immunol; 2023; 14():1289434. PubMed ID: 38304255
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Targeting interleukin-17 in radiation-induced toxicity and cancer progression.
    Baindara P
    Cytokine Growth Factor Rev; 2024 Feb; 75():31-39. PubMed ID: 38242827
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Integration of dosimetric parameters, clinical factors, and radiomics to predict symptomatic radiation pneumonitis in lung cancer patients undergoing combined immunotherapy and radiotherapy.
    Nie T; Chen Z; Cai J; Ai S; Xue X; Yuan M; Li C; Shi L; Liu Y; Verma V; Bi J; Han G; Yuan Z
    Radiother Oncol; 2024 Jan; 190():110047. PubMed ID: 38070685
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Semisynthesis of 5-O-ester derivatives of renieramycin T and their cytotoxicity against non-small-cell lung cancer cell lines.
    Buaban K; Innets B; Petsri K; Sinsook S; Chanvorachote P; Chansriniyom C; Suwanborirux K; Yokoya M; Saito N; Chamni S
    Sci Rep; 2023 Dec; 13(1):21485. PubMed ID: 38057385
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Dosimetric predictors of radiation pneumonitis in patients with prior immunotherapy exposure: A multi-institutional analysis.
    Bi J; Meng R; Yang D; Li Y; Cai J; Zhang L; Qian J; Xue X; Hu S; Yuan Z; Verma V; Bi N; Han G
    Radiother Oncol; 2024 Jan; 190():110040. PubMed ID: 38042497
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A Misleading Case of NTRK-Rearranged Papillary Thyroid Carcinoma.
    Germani MM; Boccaccio C; Matrone A; Molinaro E; Alì G; Giordano M; Elisei R; Fontanini G; Cremolini C
    Oncologist; 2024 Jan; 29(1):84-88. PubMed ID: 38037189
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeting oncogenic tert promoter variants by allele-specific epigenome editing.
    Kouroukli AG; Rajaram N; Bashtrykov P; Kretzmer H; Siebert R; Jeltsch A; Bens S
    Clin Epigenetics; 2023 Nov; 15(1):183. PubMed ID: 37993930
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell lung cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series.
    Gross AJ; Sheikh S; Kharouta M; Chaung K; Choi S; Margevicius S; Fu P; Machtay M; Bruno DS; Dowlati A; Biswas T
    Clin Lung Cancer; 2023 Dec; 24(8):696-705. PubMed ID: 37993218
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Intrathoracic Progression Is Still the Most Dominant Failure Pattern after First-Line Chemo-immunotherapy in Extensive-Stage Small-Cell lung cancer: Implications for Thoracic Radiotherapy.
    Kim D; Kim HJ; Wu HG; Lee JH; Kim S; Kim TM; Kim JS; Kim BH
    Cancer Res Treat; 2024 Apr; 56(2):430-441. PubMed ID: 37933113
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases.
    Bai K; Chen X; Qi X; Zhang Y; Zou Y; Li J; Yu L; Li Y; Jiang J; Yang Y; Liu Y; Feng S; Bu H
    J Neurooncol; 2023 Oct; 165(1):149-160. PubMed ID: 37897649
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 31.